IP Library › Assignment 010567/0917
Patent Assignment
Reel/Frame 010567/0917

Assignment of Assignor's Interest

Recorded: 2000-02-07 Pages: 22
Assignor
CYTOTHERAPEUTICS, INC.
Executed: 1999-12-29
Assignee
NEUROTECH S.A.
4, RUE PIERRE FONTAINE, BATIMENT GENOPOLE-INDUSTRIES, 91000 EVRY, FRANCE
Covered Properties (45)
Method for Producing Self-Reproducing Mammalian Pancreatic Islet-Like Structures
Patent: 4,439,521 →
Application: 06/313,494 →
Glucose Responsive Insulin Secreting Beta-Cell Lines and Method for Producing Same
Patent: 5,534,404 →
Application: 08/208,873 →
Polymeric Gene Delivery System
Application: 08/213,668 →
Method for Implanting Encapsulated Cells in a Host
Patent: 5,550,050 →
Application: 08/228,403 →
Microdrive for Use in Stereotactic Surgery
Patent: 5,643,286 →
Application: 08/265,242 →
Methods and Compositions of Growth Control for Cells Encapsulated Within Bioartificial Organs
Patent: 5,935,849 →
Application: 08/279,773 →
Nerve Guidance Channel Containing Bioartificial Three-Dimensional Hydrogel Extracellular Matrix Derivatized with Cell Adhesive Peptide Fragment
Patent: 5,834,029 →
Application: 08/280,646 →
Encapsulated PC12 Cell Transplants for Treatment of Parkinson's Disease
Patent: 5,853,385 →
Application: 08/296,967 →
Inner-Supported, Biocompatible Cell Capsules
Patent: 5,786,216 →
Application: 08/337,555 →
Controlling Proliferation of Cells Before and After Encapsulation in a Bioartificial Organ by Gene Transformation
Patent: 5,843,431 →
Application: 08/432,698 →
Methods and Compositions of Growth Control for Cells Encapsulated Within Bioartificial Organs
Patent: 5,853,717 →
Application: 08/447,356 →
Methods and Compositions of Growth Control for Cells Encapsulated Within Bioartificial Organs
Patent: 5,833,979 →
Application: 08/447,771 →
A Method for Controlling the Distribution of Cells Within a Bioartificial Organ Using Polyethylene Oxide-Poly(Dimethylsiloxane)Copolymer
Patent: 5,776,747 →
Application: 08/447,778 →
Control of Cell Growth in a Bioartificial Organ with Extracellular Matrix Coated Microcarriers
Patent: 5,858,747 →
Application: 08/447,810 →
Mx-1 Conditionally Immortalized Cells
Patent: 6,392,118 →
Application: 08/447,997 →
Method for Controlling Prolifertion and Differentiation of Cells Encapsulated Within Bioartificial Organs
Patent: 5,795,790 →
Application: 08/448,201 →
Methods for Making Immunoisolatory Implantable Vehicles with a Bio- Compatible Jacket and a Biocompatible Matrix Core
Patent: 5,834,001 →
Application: 08/449,214 →
Methods for Coextruding Immunoisolatory Implantable Vehicles with a Biocompatible Jacket and a Biocompatible Matrix Core
Patent: 5,800,829 →
Application: 08/449,274 →
Inner Supported Biocompatible Cell Capsules
Patent: 5,773,286 →
Application: 08/449,568 →
Delivery of Biologically Active Molecules Using Cells Contained in Bicompatible Immunoisolatory Capsules
Patent: 5,639,275 →
Application: 08/449,756 →
Compositions and Methods for the Delivery of Biologically Active Molecules Using Cells Contained in Biocompatible Capsules
Patent: 5,656,481 →
Application: 08/449,946 →
Compositions and Methods for the Delivery of Biologically Active Molecules Using Genetically Altered Cells Contained in Biocompatible Immunoisolatory Capsules
Patent: 5,676,943 →
Application: 08/450,316 →
Compositions and Methods for the Delivery of Biologically Active Molecules Using Genetically Altered Cells Contained in Biocompatible Immunoisolatory Capsules
Patent: 5,908,623 →
Application: 08/450,862 →
Compositions and Methods for the Delivery of Biologically Active Molecules Using Cells Contained in Biocompatible Capsules
Patent: 5,653,975 →
Application: 08/451,044 →
Glucose Responsive Insulin Secreting B-Cell Lines and Method for Producing Same
Patent: 5,773,255 →
Application: 08/464,974 →
Microporous Macrocapsules
Patent: 6,337,088 →
Application: 08/465,392 →
Polymeric Gene Delivery System
Application: 08/467,811 →
Pain Cell Line
Application: 08/481,917 →
Bioartificial Organ Containing Cells Encapsulated in a Permselective Polyether Suflfone Membrane
Patent: 5,837,234 →
Application: 08/488,317 →
Method for Treating Ophthalmic Diseases
Patent: 5,904,144 →
Application: 08/620,982 →
Device and Method for Encapsulated Gene Therapy
Patent: 6,027,721 →
Application: 08/650,726 →
Biocompatible Devices with Foam Scaffolds
Patent: 6,054,142 →
Application: 08/690,969 →
Method for Implanting Encapsulated Cells in a Host
Application: 08/722,096 →
Microdrive for Use in Stereotactic Surgery
Patent: 5,871,487 →
Application: 08/814,594 →
Cell Line Producing Analgesic Compounds for Treating Pain
Application: 08/973,580 →
Polymeric Gene Delivery System
Patent: 6,262,034 →
Application: 08/978,522 →
Membrane Formed by an Acrylonitrile-Based Polymer
Patent: 6,180,007 →
Application: 09/016,518 →
Device and Method for Treating Ophthalmic Diseases
Patent: 6,299,895 →
Application: 09/155,066 →
Bioartificial Extracellular Matrix Containing Hydrogel Matrix Derivatized with Cell Adhesive Peptide Afragment
Patent: 6,156,572 →
Application: 09/160,654 →
Polymeric Gene Delivery System
Patent: 6,475,779 →
Application: 09/173,205 →
Publication: US 2001/0051608
Cell Surface Molecule-Induced Macrophage Activation
Patent: 6,197,294 →
Application: 09/178,869 →
Biocompatible Devices with Foam Scaffolds
Patent: 6,231,879 →
Application: 09/230,506 →
Compositions for the Delivery of Biologically Active Molecules Using Genetically Altered Cells Contained in Biocompatible Immunoisolatory Capsules
Patent: 6,264,941 →
Application: 09/236,246 →
Cells or Tissue Attached to a Non- Degradable Filamentous Matrix Encapsulated by a Semi- Permeable Membrane
Patent: 6,303,136 →
Application: 09/289,999 →
Arpe-19 Cells for Encapsulation
Application: 60/127,926 →
Related Assignments (24)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignors Interest. Mar 1, 1982
From: ARCHER, MICHAEL C.; JAIN, KANTI
To: ONTARIO CANCER INSTITUTE;
Reel/Frame 003983/0365 →
Assignment of Assignor's Interest May 20, 1994
From: MATHIOWITZ, EDITH; JONG, YONG SHIK; BOEKELHEIDE, KIM
To: BROWN UNIVERSITY RESEARCH FOUNDATION
Reel/Frame 007018/0416 →
Assignment of Assignor's Interest Jun 13, 1994
From: LAURANCE, MEGAN E.; KNAACK, DAVID; FIORE, DEBORAH M.; HEGRE, ORION D.
To: CYTOTHERAPEUTICS
Reel/Frame 007020/0956 →
Assignment of Assignor's Interest Jul 5, 1994
From: HOLLAND, LAURA M.; HAMMANG, JOSEPH P.; RUDNICK, SETH A.; LYSAGHT, MICHAEL J.
To: CYTOTHERAPEUTICS, INC.
Reel/Frame 007050/0432 →
Assignment of Assignor's Interest Aug 8, 1994
From: WARNER, NICHOLAS; GODDARD, MOSES; MILLS, JOHN
To: CYTOTHERAPEUTICS, INC.
Reel/Frame 007090/0364 →
Assignment of Assignor's Interest Nov 7, 1994
From: BELLAMKONDA, RAVI; RANIERI, JOHN P.; AEBISCHER, PATRICK
To: CYTOTHERAPEUTICS, INC.
Reel/Frame 007196/0406 →
Assignment of Assignor's Interest Nov 14, 1994
From: SCHINSTINE, MALCOLM; SHOICHET, MOLLY S.; GENTILE, FRANK T.; HAMMANG, JOSEPH P.
To: CYTOTHERAPEUTICS, INC.
Reel/Frame 007198/0318 →
Assignment of Assignor's Interest Feb 13, 1995
From: EMERICH, DWAINE F.; AEBISCHER, PATRICK; KORDOWER, JEFFREY H.
To: CYTOTHERAPEUTICS, INC.
Reel/Frame 007324/0898 →
Assignment of Assignor's Interest Apr 3, 1995
From: DIONNE, KEITH E.; HEGRE, ORION D.; FLANAGAN, THOMAS R.; HAZLETT, TYRONE F.
To: CYTOTHERAPEUTICS, INC.
Reel/Frame 007404/0697 →
Assignment of Assignor's Interest Jul 13, 1995
From: SCHINSTINE, MALCOLM; SHOICHET, MOLLY S.; GENTILE, FRANK T.; HAMMANG, JOSEPH P.
To: CYTOTHERAPEUTICS, INC.
Reel/Frame 007604/0344 →
Assignment of Assignor's Interest Jul 28, 1995
From: BAETGE, EDWARD E.; HAMMANG, JOSEPH P.; GENTILE, FRANK T.; LINDNER, MARK D.
To: CYTOTHERAPEUTICS, INC.
Reel/Frame 007556/0745 →
Assignment of Assignor's Interest Jul 28, 1995
From: BAETGE, EDWARD E.; HAMMANG, JOSEPH P.; GENTILE, FRANK T.; LINDNER, MARK D.
To: CYTOTHERAPEUTICS, INC.
Reel/Frame 007559/0299 →
Assignment of Assignor's Interest Jul 28, 1995
From: BAETGE, EDWARD E.; HAMMANG, JOSEPH P.; GENTILE, FRANK T.; LINDNER, MARK D.
To: CYTOTHERAPEUTICS, INC.
Reel/Frame 007581/0661 →
Assignment of Assignor's Interest Jul 28, 1995
From: BAETGE, EDWARD E.; HAMMANS, JOSEPH P.; GENTILE, FRANK T.; LINDNER, MARK D.
To: CYTOTHERAPEUTICS, INC.
Reel/Frame 007556/0697 →
Assignment of Assignor's Interest Jul 28, 1995
From: BAETGE, EDWARD E.; HAMMANG, JOSEPH P.; GENTILE, FRANK T.; LINDNER, MARK D.
To: CYTOTHERAPEUTICS, INC.
Reel/Frame 007556/0912 →
Assignment of Assignor's Interest May 8, 1996
From: MESSING, ALBEE
To: CYTOTHERAPEUTICS, INC.
Reel/Frame 007931/0762 →
Assignment of Assignor's Interest Jul 18, 1996
From: CYTOTHERAPEUTICS, INC.
To: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY, A DIVISION OF YESHIVA UNIVERSITY
Reel/Frame 008050/0160 →
This Is a Corrected Assignment to Remove the 41 United Stated Patents Listed on the Attached Schedule a from the Assignment Recorded on March 8, 2000 at Reel/Frame 010567/0917. the Conveying Party Did Not Have an Assignable Interest in These Patents. Thus, These Documents Were Inadvertently Included on the Recordation Form Cover Sheet Filed on February 7, 2000 and Should Be Removed. Oct 12, 2005
From: CYTOTHERAPEUTICS, INC.
To: NEUROTECH S.A.
Reel/Frame 017145/0800 →
Corrective Assignment to Remove Property Numbers: 4,868,121, 5,322,790 and 07/922,111, Previously Recorded at Reel 010567 Frame 0917. Oct 12, 2005
From: CYTO THERAPEUTIS, INC.
To: NEUROTECH S.A.
Reel/Frame 016902/0648 →
Assignment of Assignor's Interest Dec 12, 2005
From: CYTOTHERAPEUTICS, INC.
To: NEUROTECH S.A.
Reel/Frame 017073/0187 →
Assignment of Assignor's Interest Apr 5, 2006
From: CYTOTHERAPEUTICS, INC.
To: NEUROTECH S.A.
Reel/Frame 017794/0001 →
Assignment of Assignor's Interest Feb 11, 2008
From: NEUROTECH, S.A.
To: NEUROTECH USA, INC.
Reel/Frame 020487/0321 →
Security Agreement Dec 23, 2010
From: NEUROTECH USA, INC.
To: LFG AMERICA PTY LIMITED
Reel/Frame 025562/0340 →
Confirmatory License Jan 5, 2011
From: ONTARIO CANCER INSTITUTE, THE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 025584/0230 →